Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 1,033-1,044 of 23,847
Drug study icon
RecruitingNCT06575751

Cannabidiol and Cannabis Concentrate Users

This summary needs review. Please check the official study record and contact the research team for details.

In Aurora
AddictionDrugA study involving a medication or substance.From 25 Years to 60 Years
Countries
United States
Sponsor
University of Colorado, Denver
Condition
Addiction
Drug study icon
RecruitingNCT06290063

Cannabidiol and Older Adult Cannabis Users

This study is looking at care and outcomes for people with Sleep, Anxiety, Depression, or Pain. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

In Boulder
Anxiety, DepressionDrugOver 60 Years
Countries
United States
Sponsor
University of Colorado, Boulder
Condition
Anxiety, Depression
Drug study icon
RecruitingNCT05283382

Cannabidiol Effects on Learning and Anxiety

This study exists to see whether a medication treatment can make care clearer and more responsive. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.

In Storrs
AnxietyDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
University of Connecticut
Condition
Anxiety
Drug study icon
RecruitingNCT05867849

Cannabidiol for Depression in bipolarity (CBD-BD)

This study is comparing Cannabidiol with placebo for people with bipolarity. Participants receive Cannabidiol or placebo and complete study visits and assessments.

Multiple locations, including Vancouver
Bipolarity, DepressionDrugFrom 19 Years to 70 Years
Countries
Canada
Sponsor
University of British Columbia
Condition
Bipolarity, Depression
Drug study icon
RecruitingNCT06218056

Cannabidiol for Reducing Cigarette Use

This summary needs review. Please check the official study record and contact the research team for details.

In North Hollywood
AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Addiction
Drug study icon
RecruitingNCT05066308

Cannabidiol for Reduction of Brain Neuroinflammation

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.

In Boston
DepressionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression
Drug study icon
RecruitingISRCTN10334895

Cannabidiol for patients at a high-risk of psychosis

This study is testing a medication approach for people with Clinical high-risk for psychosis, Mental and Behavioural Disorders, or Clinical high-risk state for psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United Kingdom
Sponsor
King’s College London and South London and Maudsley NHS Foundation Trust
Condition
Schizophrenia
Drug study icon
RecruitingNCT04587791

Cannabidiol in Addiction and Chronic Pain

This summary needs review. Please check the official study record and contact the research team for details.

In West Haven
AddictionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Yale University
Condition
Addiction
Drug study icon
RecruitingNCT07123467

Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder

This study is comparing Low-Dose Cannabidiol with placebo for people with Generalized anxiety or anxiety. Participants receive Low-Dose Cannabidiol or placebo and complete study visits and assessments.

In Detroit
AnxietyDrugFrom 18 Years to 45 Years
Countries
United States
Sponsor
Wayne State University
Condition
Anxiety
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.